Verrica Pharmaceuticals VRCA
NASDAQ VRCA
$3.52 -0.09 (-2.49%)
At close: Nov 10, 2026 · 4:00 PM EST

Verrica Pharmaceuticals (VRCA) Preferred Stock Liabilities (2017)

Updated

Verrica Pharmaceuticals (VRCA) posted Preferred Stock Liabilities of $15.51 million for Q4 2017.

Analysis

Verrica Pharmaceuticals (VRCA) Preferred Stock Liabilities (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Verrica Pharmaceuticals 62.02 Mn -21.03 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 15.51 Mn
API Access

Verrica Pharmaceuticals Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=VRCA&period=max&api_key=YOUR_API_KEY